Table 3 Short vs. long half-life benzodiazepines prescribed to patients older than 65 years (France, 2011-2012)
From: Did the new French pay-for-performance system modify benzodiazepine prescribing practices?
2011 | 2012 | ||
|---|---|---|---|
N = 9,894 | N = 10,839 | p | |
n; % | n; % | ||
Short half-life BZDa | 4,601; 46.50 | 5,550; 51.20 | <0.005 |
Clotiazepam | 118; 1.19 | 137; 1.26 | 0.69 |
Oxazepam | 723; 7.31 | 997; 9.20 | <0.005 |
Lorazepam | 962; 9.72 | 1,043; 9.62 | 0.83 |
Alprazolam | 2,798; 28.28 | 3,373; 31.12 | <0.005 |
Long half-life BZDa | 5,293; 53.50 | 5,289; 48.80 | <0.005 |
Bromazepam | 4,120; 41.64 | 3,907; 36.05 | <0.005 |
Clobazam | 115; 1.16 | 174; 1.61 | 0.008 |
Diazepam | 64; 0.65 | 189; 1.74 | <0.005 |
Ethyl loflazepate | 112; 1.13 | 113; 1.04 | 0.58 |
Prazepam | 624; 6.31 | 664; 6.13 | 0.61 |
Nordazepam | 101; 1.02 | 98; 0.90 | 0.43 |
Potassium clorazepate | 157; 1.59 | 144; 1.33 | 0.13 |